Chargement en cours...
The place of intravenous immunoglobulin in rheumatic diseases
Therapy with intravenous human immunoglobulin (IVIG) was and continues to remain essential for a number of diseases. At the same time the evidence base for IVIG use is extremely small in rheumatology. Clinical experience shows that IVIG is effective in treating thrombocytopenic purpura, Guillain–Bar...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | Artigo |
Langue: | Russo |
Publié: |
IMA-PRESS LLC
2016-01-01
|
Collection: | Современная ревматология |
Sujets: | |
Accès en ligne: | https://mrj.ima-press.net/mrj/article/view/655 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|